Login / Signup

A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering.

Jingen ZhuNeeti AnanthaswamySwati JainHimanshu BatraWei-Chun TangDouglass A LewryMichael L RichardsSunil A DavidPaul B KilgoreJian ShaAleksandra DrelichChien-Te Kent TsengAshok K ChopraVenigalla B Rao
Published in: Science advances (2021)
[Figure: see text].
Keyphrases
  • sars cov
  • high throughput
  • genome editing
  • crispr cas
  • genome wide
  • respiratory syndrome coronavirus
  • smoking cessation
  • real time pcr
  • iron oxide
  • single cell